SEC 13F Intelligence

Managers / Q3 2020 · view latest →

Bain Capital Public Equity Management II, LLC

CIK 0001768111 · 200 CLARENDON STREET, BOSTON, MA, 02116 · 6175162000

Reported Value
$1.5B
Q3 2020
Positions
43
Filings on Record
30
2019–present window
Filed
Nov 16, 2020
original filing

Summary

Bain Capital Public Equity Management II, LLC reported $1.5B in U.S.-listed holdings across 43 positions for Q3 2020.

Its largest position, DOCU, represents 11.4% of the portfolio.

Compared with Q2 2020, the fund opened 10 new positions and exited 12.

Portfolio Metrics

Turnover
+21.8%
vs prior filed quarter
Top-10 Concentration
+55.9%
share of reported value
Largest Position
+11.4%
Docusign
New / Exited
10 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $124MQ1 ’19Q2 ’19: $1.1BQ3 ’19: $1.1BQ4 ’19: $1.1BQ1 ’20: $854MQ1 ’20Q2 ’20: $1.3BQ3 ’20: $1.5BQ4 ’20: $2.0BQ1 ’21: $2.4BQ1 ’21Q2 ’21: $2.3BQ3 ’21: $2.9BQ4 ’21: $3.0BQ1 ’22: $3.1BQ1 ’22Q2 ’22: $2.0BQ3 ’22: $1.9BQ4 ’22: $1.8BQ1 ’23: $1.8BQ1 ’23Q2 ’23: $1.9BQ3 ’23: $2.1BQ4 ’23: $2.4BQ1 ’24: $2.5BQ1 ’24Q2 ’24: $2.4BQ3 ’24: $2.3BQ4 ’24: $2.2BQ1 ’25: $1.3BQ1 ’25Q2 ’25: $2.1BQ3 ’25: $2.1BQ4 ’25: $62MQ1 ’26: $0Q1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 87.1%ADR: 8.5%Other: 4.2%ETP: 0.3%
  • Common Stock · 87.1% · $1.3B
  • ADR · 8.5% · $129M
  • Other · 4.2% · $63M
  • ETP · 0.3% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
FISVFISERV INCNEW+735.7K735.7K+$76M$76M
NICENICE LTDNEW+304.6K304.6K+$69M$69M
EXPEEXPEDIA GROUP INCNEW+655.4K655.4K+$60M$60M
AONAON PLCNEW+249.7K249.7K+$52M$52M
SDGRSCHRODINGER INCNEW+580.9K580.9K+$28M$28M
DRAGONEER GROWTH OPPORTUN CONEW+2.00M2.00M+$25M$25M
HORIZON THERAPEUTICS PUB LNEW+282.0K282.0K+$22M$22M
UUNITY SOFTWARE INCNEW+200.0K200.0K+$17M$17M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

37 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1DOCUDOCUSIGN INChistory →COM11.37%$172M800.0K
2ANAPLAN INCCOM6.40%$97M1.55M
3CCKCROWN HLDGS INChistory →COM6.19%$94M1.22M
4MSFTMICROSOFT CORPhistory →COM5.65%$86M407.2K
5FISVFISERV INChistory →COM5.01%$76M735.7K
6FISFIDELITY NATL INFORMATION SVhistory →COM4.78%$72M492.3K
7NICENICE LTDhistory →SPONSORED ADR4.57%$69M304.6K
8EYENATIONAL VISION HLDGS INChistory →COM4.19%$63M1.66M
9EXPEEXPEDIA GROUP INChistory →COM NEW3.97%$60M655.4K
10BALLBALL CORPhistory →COM3.82%$58M695.4K
11FIVNFIVE9 INChistory →COM3.65%$55M425.8K
12AMZNAMAZON COM INChistory →COM3.58%$54M17.2K
13TJXTJX COS INC NEWhistory →COM3.53%$53M959.9K
14AONAON PLChistory →SHS CL A3.40%$52M249.7K
15WHWYNDHAM HOTELS & RESORTS INChistory →COM3.19%$48M956.0K
16CBCHUBB LIMITEDhistory →COM3.13%$47M408.6K
17BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS3.11%$47M160.1K
18RNRRENAISSANCERE HOLDINGS LTDhistory →COM2.70%$41M240.9K
19DRAFTKINGS INCCOM CL A2.42%$37M623.9K
20SDGRSCHRODINGER INChistory →COM1.82%$28M580.9K
21EGEVEREST RE GROUP LTDhistory →COM1.79%$27M136.9K
22DRAGONEER GROWTH OPPORTUN COUNIT 08/18/20271.62%$25M2.00M
23ADPTADAPTIVE BIOTECHNOLOGIES CORhistory →COM1.60%$24M497.4K
24HORIZON THERAPEUTICS PUB LSHS1.45%$22M282.0K
25GLOBAL BLOOD THERAPEUTICS INCOM1.39%$21M381.9K
26UUNITY SOFTWARE INChistory →COM1.15%$17M200.0K
27UBERUBER TECHNOLOGIES INChistory →COM1.08%$16M450.2K
28SNYSANOFIhistory →SPONSORED ADR0.83%$13M249.2K
29CLDRCLOUDERA INCCOM0.49%$7M686.8K
30AFFIMED N VCOM0.48%$7M2.15M
31IQVIQVIA HLDGS INCCOM0.40%$6M38.0K
32ASSEMBLY BIOSCIENCES INCCOM0.39%$6M358.0K
33FOURSHIFT4 PMTS INCCL A0.32%$5M100.0K
34TRANSLATE BIO INCCOM0.21%$3M237.5K
35PROTEOSTASIS THERAPEUTICS INCOM0.05%$725,000659.4K
36DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW0.04%$557,000128.9K
37CURIS INCCOM NEW0.00%$51,00043.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$01May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$62M3Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$2.1B21Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$2.1B24Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.3B16May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.2B27Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.3B33Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.4B35Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.5B29May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$2.4B29Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.1B31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.9B32Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.8B31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.8B30Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.9B35Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$2.0B39Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$3.1B43May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.0B45Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$2.9B54Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.3B51Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$2.4B61May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$2.0B43Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.5B43Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.3B45Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$854M39May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B38Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.1B52Feb 12, 2020RESTATEMENTchanges · EDGAR ↗
Q2 2019$1.1B56Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$124M10May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.